PT  - JOURNAL ARTICLE
AU  - Walker, R
AU  - Phillips, B
AU  - Dias, S
TI  - Comparison of Bayesian methods for incorporating adult clinical trial data to improve certainty of treatment effect estimates in children
AID  - 10.1101/2023.02.02.23285367
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.02.02.23285367
4099  - http://medrxiv.org/content/early/2023/02/02/2023.02.02.23285367.short
4100  - http://medrxiv.org/content/early/2023/02/02/2023.02.02.23285367.full
AB  - There are challenges associated with recruiting children to take part in randomised clinical trials and as a result, compared to adults, in many disease areas we are less certain about which treatments are most safe and effective. This can lead to weaker recommendations about which treatments to prescribe in practice. However, it may be possible to ‘borrow strength’ from adult evidence to improve our understanding of which treatments work best in children, and many different statistical methods are available to conduct these analyses. In this paper we discuss Bayesian methods for extrapolating adult clinical trial evidence to children. Using an exemplar dataset, we compare the effect of modelling assumptions on the estimated treatment effect and associated heterogeneity. We finally discuss the appropriateness of different modelling assumptions in the context of estimating treatment effect in children.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by an NIHR Pre-doctoral Fellowship award (Round 1) NIHR300469 held by RW. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is a secondary analysis using agreggate data from clincial trial publications and therefore does not require ethical approal.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.